Agilent Technologies and the University of Technology, Sydney (UTS) in Australia have established a joint nuclear MR (NMR) research facility.
The NMR facility will be home to technologies to support a range of UTS staff and student research projects, including identifying and measuring drug treatments for osteoporosis, as well as analyzing solid tissue samples and bacteria in search of more effective treatments for osteoporosis.
This joint NMR facility (a first for Agilent in South Asia Pacific) is part of an ongoing research and technology collaboration between UTS and the Santa Clara, Calif.-based Agilent. The two organizations established an elemental bio-imaging facility in 2008.
Nuclear MR spectroscopy is a research technique that exploits the magnetic properties of certain atomic nuclei to determine the physical and chemical properties of atoms, or the molecules in which they are contained. It relies on the phenomenon of nuclear magnetic resonance and can provide detailed information about the structure, dynamics, reaction state and chemical environment of molecules.